mitomycin has been researched along with Dermatitis Medicamentosa in 18 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 23 cases of primary advanced breast cancer, intra-arterial infusion chemotherapy of Adriamycin (ADR) and Mitomycin C (MMC), which were injected jointly or individually, was performed and its effects and side effects were studied." | 7.67 | [Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin]. ( Asaishi, K; Ebata, T; Hayasaka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, N; Toda, K; Totsuka, M, 1985) |
| "Bladder cancer is a heterogeneous disease: approximately 75% of its forms are non muscle invasive neoplasms." | 6.46 | Mitomycin C for the treatment of bladder cancer. ( Bassi, PF; Cappa, E; D'Agostino, D; Filianoti, A; Racioppi, M; Volpe, A, 2010) |
| "In 23 cases of primary advanced breast cancer, intra-arterial infusion chemotherapy of Adriamycin (ADR) and Mitomycin C (MMC), which were injected jointly or individually, was performed and its effects and side effects were studied." | 3.67 | [Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin]. ( Asaishi, K; Ebata, T; Hayasaka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, N; Toda, K; Totsuka, M, 1985) |
| "Bladder cancer is a heterogeneous disease: approximately 75% of its forms are non muscle invasive neoplasms." | 2.46 | Mitomycin C for the treatment of bladder cancer. ( Bassi, PF; Cappa, E; D'Agostino, D; Filianoti, A; Racioppi, M; Volpe, A, 2010) |
| "The treatment of anal cancer is based on concomitant radiotherapy and chemotherapy and is associated with a nonnegligible rate of local severe toxicities that can strongly impair the quality of life." | 1.39 | Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. ( Benezery, K; Doyen, J; Follana, P; Francois, E; Gal, J; Gérard, JP; Hannoun-Levi, JM; Ortholan, C, 2013) |
| "However, drug eruptions after the second instillation of epirubicin and the first instillation of mitomycin C might have been due to allergic reactions to the drugs." | 1.35 | Drug eruption due to intravesical instillations of both epirubicin and mitomycin C. ( Fuse, H; Imamura, T; Kaji, K; Oishi, N; Okumura, A, 2009) |
| "Mitomycin C is an alkylating agent, used by intravesical instillation to treat carcinoma of the bladder." | 1.28 | Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction? ( Colver, GB; Hunter, JA; Inglis, JA; McVittie, E; Spencer, MJ; Tolley, DA, 1990) |
| "Effect of this treatment on the pain could be evaluated in 16 patients." | 1.27 | Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycin. ( Chuang, VP; Claghorn, L; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1985) |
| "Patients with multiple bladder tumors, bladder tumors inaccessible to endoscopic resection, or lesions too extensive to completely resect, or with medial contraindications for endoscopic resection procedures, were included in these studies." | 1.27 | Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor. ( Gonder, M; Hu, KN; Khan, AS; Kim, A; Soroff, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyen, J | 1 |
| Benezery, K | 1 |
| Follana, P | 1 |
| Ortholan, C | 1 |
| Gérard, JP | 1 |
| Hannoun-Levi, JM | 1 |
| Gal, J | 1 |
| Francois, E | 1 |
| Cicek, D | 1 |
| Cobanoglu, B | 1 |
| Inci, R | 1 |
| Dertlioglu, SB | 1 |
| Kokcam, I | 1 |
| Elkiran, T | 1 |
| Okumura, A | 1 |
| Oishi, N | 1 |
| Kaji, K | 1 |
| Imamura, T | 1 |
| Fuse, H | 1 |
| Volpe, A | 1 |
| Racioppi, M | 1 |
| D'Agostino, D | 1 |
| Cappa, E | 1 |
| Filianoti, A | 1 |
| Bassi, PF | 1 |
| Calistru, AM | 1 |
| Baudrier, T | 1 |
| Mota, A | 1 |
| Alexandrescu, D | 1 |
| Cunha, AL | 1 |
| Silva, J | 1 |
| Azevedo, F | 1 |
| Andreu-Barasoain, M | 1 |
| Gómez de la Fuente, E | 1 |
| Pinedo, F | 1 |
| Nuño, A | 1 |
| López-Estebaranz, JL | 1 |
| Ritch, PS | 1 |
| Louie, AC | 1 |
| Neild, VS | 1 |
| Sanderson, KV | 1 |
| Riddle, PR | 1 |
| Nissenkorn, I | 1 |
| Herrod, H | 1 |
| Soloway, MS | 1 |
| Echechipía, S | 1 |
| Alvarez, MJ | 1 |
| García, BE | 1 |
| Olaguíbel, JM | 1 |
| Rodriguez, A | 1 |
| Lizaso, MT | 1 |
| Acero, S | 1 |
| Tabar, AI | 1 |
| Vidal, C | 1 |
| de la Fuente, R | 1 |
| González Quintela, A | 1 |
| Arregui, MA | 1 |
| Aguirre, A | 1 |
| Gil, N | 1 |
| Goday, J | 1 |
| Ratón, JA | 1 |
| Colver, GB | 1 |
| Inglis, JA | 1 |
| McVittie, E | 1 |
| Spencer, MJ | 1 |
| Tolley, DA | 1 |
| Hunter, JA | 1 |
| Arrizabalaga, M | 1 |
| Casanueva, T | 1 |
| Benítez, J | 1 |
| Escribano, G | 1 |
| Gallardo, C | 1 |
| Toda, K | 1 |
| Asaishi, K | 1 |
| Okazaki, A | 1 |
| Okazaki, Y | 1 |
| Okazaki, M | 1 |
| Ebata, T | 1 |
| Totsuka, M | 1 |
| Hayasaka, H | 1 |
| Sato, N | 1 |
| Narimatsu, E | 1 |
| Sala, F | 1 |
| Crosti, C | 1 |
| Bencini, PL | 1 |
| Perotta, E | 1 |
| Mansi, M | 1 |
| Patt, YZ | 1 |
| Peters, RE | 1 |
| Chuang, VP | 1 |
| Wallace, S | 1 |
| Claghorn, L | 1 |
| Mavligit, G | 1 |
| Hu, KN | 1 |
| Kim, A | 1 |
| Khan, AS | 1 |
| Soroff, H | 1 |
| Gonder, M | 1 |
1 review available for mitomycin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Mitomycin C for the treatment of bladder cancer.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Clinical Trials as Topic; Drug Eruptions; | 2010 |
17 other studies available for mitomycin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Brac | 2013 |
A very rare side effect of mitomycin-C: psoriasiform drug eruption.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Drug Eruptions; Female; Humans; Middle Aged; Mitomyci | 2013 |
Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Drug Eruptions; Epirubicin; Humans; Male; | 2009 |
Pseudoscleroderma possibly induced by intravesical instillation of mitomycin C.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Drug Eruptions; Humans; Male; Mitom | 2010 |
Intravesical mitomycin C-induced generalized pustular folliculitis.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Drug Eruptions; Folliculitis; Humans; Mal | 2012 |
Skin rash following therapy with mitomycin C.
Topics: Adenocarcinoma; Adult; Drug Eruptions; Humans; Lung Neoplasms; Male; Mitomycin; Mitomycins | 1984 |
Dermatitis due to mitomycin bladder instillations.
Topics: Aged; Carcinoma, Transitional Cell; Drug Eruptions; Humans; Male; Mitomycin; Mitomycins; Urinary Bla | 1984 |
Side effects associated with intravesical mitomycin.
Topics: Aged; Carcinoma, Transitional Cell; Drug Eruptions; Female; Humans; Male; Middle Aged; Mitomycin; Mi | 1981 |
Generalized dermatitis due to mitomycin C patch test.
Topics: Aged; Antibiotics, Antineoplastic; Drug Eruptions; Humans; Hypersensitivity, Delayed; Male; Mitomyci | 1995 |
Three cases of allergic dermatitis due to intravesical mitomycin C.
Topics: Administration, Intravesical; Aged; Drug Eruptions; Humans; Male; Mitomycin; Urinary Bladder Neoplas | 1992 |
Dermatitis due to mitomycin C bladder instillations: study of 2 cases.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitiona | 1991 |
Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Alkylating Agents; Antigen-Presenting Cells; | 1990 |
[Massive secondary psoriasiform dermatitis secondary to intravesical administration of mitomycin C].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Drug Eruptions; Humans; Kidney Neoplasms; | 1989 |
[Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin].
Topics: Alopecia; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Eruptions; Female; Human | 1985 |
[Toxicoallergic exanthema caused by intravesical instillation of mitomycin C].
Topics: Administration, Intravesical; Aged; Drug Eruptions; Exanthema; Humans; Male; Mitomycin; Mitomycins; | 1987 |
Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; C | 1985 |
Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Cystosco | 1985 |